On July 1, 2024, Takeda Italia announced two strategic appointments to its leadership team. Chiara Giorgi has been appointed Gastroenterology Business Unit Head, while Davide Borrelli has assumed the role of Head of Strategy & Innovation, Neuroscience & Vaccines. Both professionals were chosen for their proven experience and demonstrated value in the pharmaceutical sector, as well as for the path undertaken in Takeda Italia. The appointments are an important step for the global biopharmaceutical company, which is preparing to face future challenges with strengthened leadership. As highlighted by Takeda Italia, «with these two appointments, Takeda Italia is preparing to face the important challenges of the coming months. Chiara Giorgi will ensure a clear strategic direction for the Gastroenterology team, contributing to the achievement of the company’s objectives and always keeping the needs of patients at the center», while «the appointment of Davide Borrelli guarantees the necessary focus for the management of two innovative areas for Takeda, that of vaccines and that of neuroscience».
[Se non vuoi perdere tutte le novità iscriviti gratis alla newsletter di FarmaciaVirtuale.it. Arriva nella tua casella email alle 7 del mattino. Apri questo link]
Therapeutic areas of excellence for the company
Giorgi commented on the appointment by underlining that «this new challenge, in one of the company’s therapeutic areas of excellence, will see me committed to promoting the search for innovative solutions for gastrointestinal diseases, starting from listening to real care needs, while strengthening Takeda’s leadership in the Gastroenterology area». Borrelli highlighted that «vaccines represent a dimension of global impact for Takeda, just as research and development in neuroscience is central to improving the treatment path and the unmet needs of patients. Leading this Business Unit is a privilege and a great responsibility for me. I am committed to leading this extraordinary team towards increasingly ambitious goals, through passion, determination and the support of increasingly cutting-edge technologies. A growth path that I am proud to undertake together with my colleagues in the Takeda Italia leadership team».
Commitment to Strengthen Strategic Sectors for Takeda
Anna Maria Bencini, general manager of Takeda Italy, recalled that “in Takeda we are developing a solid pipeline for the future and these two appointments are a clear signal of our commitment to strengthen and make more strategic two key sectors for the company. I am convinced that the leadership of Chiara Giorgi and Davide Borrelli will significantly contribute to our goal of generating value for patients and maintaining Takeda as a point of reference in the pharmaceutical sector”.
